These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 25934055)

  • 1. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
    Münch D; Sahl HG
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes.
    Schmitt P; Rosa RD; Destoumieux-Garzón D
    Biochim Biophys Acta; 2016 May; 1858(5):958-70. PubMed ID: 26498397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defensive remodeling: How bacterial surface properties and biofilm formation promote resistance to antimicrobial peptides.
    Nuri R; Shprung T; Shai Y
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3089-100. PubMed ID: 26051126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the in vivo significance of bacterial resistance to antimicrobial peptides.
    Bauer ME; Shafer WM
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3101-11. PubMed ID: 25701234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Peptides: Mechanisms of Action and Resistance.
    Bechinger B; Gorr SU
    J Dent Res; 2017 Mar; 96(3):254-260. PubMed ID: 27872334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
    Schneider T; Sahl HG
    Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
    Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
    Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of bacterial sensitivity and resistance to mammalian Group IIA phospholipase A2.
    Weiss JP
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3072-7. PubMed ID: 26079797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial peptide resistance in Neisseria meningitidis.
    Tzeng YL; Stephens DS
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3026-31. PubMed ID: 26002321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside.
    Maria-Neto S; de Almeida KC; Macedo ML; Franco OL
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3078-88. PubMed ID: 25724815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.
    de Kruijff B; van Dam V; Breukink E
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):117-21. PubMed ID: 19008088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
    Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
    Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
    Grein F; Schneider T; Sahl HG
    J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.
    Malanovic N; Lohner K
    Biochim Biophys Acta; 2016 May; 1858(5):936-46. PubMed ID: 26577273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.
    Schmitt P; Wilmes M; Pugnière M; Aumelas A; Bachère E; Sahl HG; Schneider T; Destoumieux-Garzón D
    J Biol Chem; 2010 Sep; 285(38):29208-16. PubMed ID: 20605792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate analogues to study cell-wall biosynthesis and its inhibition.
    Lazar K; Walker S
    Curr Opin Chem Biol; 2002 Dec; 6(6):786-93. PubMed ID: 12470732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
    Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
    Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.